Promoter polymorphism of SLC11A1 (formerly NRAMP1) confers susceptibility to autoimmune type 1 diabetes mellitus in Japanese

Tissue Antigens

Volumn 63, Issue 3, 2004, Pages 231-236

  Takahashi, K ^a   Satoh, J ^a   Kojima, Y ^a   Negoro, K ^a   Hirai, M ^a   Hinokio, Y ^a   Kinouchi, Y ^a   Suzuki, S ^a   Matsuura, N ^b   Shimosegawa, T ^a   Oka, Y ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antigen presenting cells; Insulin dependent diabetes mellitus; Macrophage activation; Macrophages; Natural resistance; NRAMP; Polymorphism; SLC11A1

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR4 ANTIGEN; HLA DR9 ANTIGEN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; JAPAN; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 10744232197     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2004.000172.x     Document Type: Article

References (34)

1. Ashton-Rickardt PG, Bandeira A, Delaney JR et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994: 76: 651-63.
2. Rocha B, von Boehemer H. Peripheral selection of the T cell repertoire. Science 1991: 251: 1225-31.
3. Ucker DS, Meyers J, Obermiller PS. Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J Immunol 1993: 149: 1583-92.
4. Critchfield JM, Racke MK, Zuniga-Pflucker JC et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994: 263: 1139-43.
5. Takahashi K, Honeyman MC, Harrison LC. Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes. J Immunol 1998: 161: 2629-35.
6. Yokono K, Kasase Y, Nagata M, Hatamori N, Baba S. Suppression of concanavalin A-induced responses in splenic lymphocytes by activated macrophages in the non-obese diabetic mouse. Diabetologia 1989: 32: 67-73.
7. Smerdon RA, Peakman M, Hussain MJ et al. Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes 1993: 42: 127-33.
8. Serreze DV, Gaskins HR, Leiter EH. Defective activation of T suppressor cell function in nonobese diabetic mice: potential relationship to cytokine deficiencies. J Immunol 1993: 150: 2534-43.
9. Milich DR, Jones JE, McLachlan A, Houghten R, Thornton GB, Hughes JL. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence Peptide-MHC Interaction. J Immunol 1989: 143: 3148-56.
10. Mamula MJ. The inability to process a self-peptide allows autoreacrive T cells to escape tolerance. J Exp Med 1993: 17: 567-71.
11. Serreze DV, Leiter EH. Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies. J Immunol 1988: 140: 3801-7.
12. Serreze DV, Leiter EH. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium. J Immunol 1991: 147: 1222-9.
13. Merriman TR, Todd JA. Genetics of insulin-dependent diabetes: non-major histocompatibility genes. Horm Metab Res 1996: 28: 289-93.
14. Searle S, Blackwell JM. Evidence for a functional repeat polymorphism in the promoter of the human SLC11A1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 1999: 36: 295-9.
15. Copeman JB, Cucca F, Hearne CM et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33 Nat Genet 1995: 9: 80-5.
16. Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996: 5: 1075-80.
17. Morahan G, Huang D, Tait BD, Colman PG, Harrison LC. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 1996: 272: 1811-3.
18. Awata T, Kurihara S, Iitaka M et al. Association of CTLA-4 gene A-G polymorphism (JDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 1998: 47: 128-9.
19. Iwata I, Nagafuchi S, Nakashima H et al. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes 1999: 48: 416-9.
20. Hill NJ, Lyons PA, Armitage N, Todd JA, Wicker LS, Peterson LB. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and SLC11A1 loci in humans. Diabetes 2000: 49: 1744-7.
21. Bassuny WM, Ihara K, Matsuura N et al. Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes. Immunogenetics 2002: 54: 282-5.
22. Esposito L, Hill NJ, Pritchard LE et al. Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. IMDIAB Group. Diabetes 1998: 47: 1797-9.
23. Kojima Y, Kinouchi K, Takahashi S et al. Inflammatory bowel disease is associated with a novel promoter polymorphism of SLC11A1 gene. Tissue Antigens 2001: 58: 379-84.
24. Bando Y, Ushiogi Y, Toya D, Tanaka N, Fujisawa M. Antibodies to glutamic acid decarboxylase (GAD) in non-obese Japanese diabetics without insulin therapy: a comparison of two commercial RIA kits based on recombinant and pig brain GAD. Diabetes Res Clin Pract 1998: 41: 25-33.
25. Bidwell J. DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens. Immunol Today 1988: 9: 18-23.
26. Imahashi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992: 1065-220.
27. Kawabata Y, Ikegami H, Kawaguchi Y et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 2002: 51: 545-51.
28. Ouchi K, Suzuki Y, Shirakawa T, Kishi F. Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J Infect Dis 2003: 187: 326-9.
29. Gao PS, Fujishima S, Mao XQ et al. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin Genet 2000: 58: 74-6.
30. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998: 102: 1369-76.
31. Li LC, Chui RM, Sasaki M et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000: 60: 873-6.
32. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999: 42: 1101-8.
33. Yang YS, Kim SJ, Kim JW, Koh EM. NRAMP1 gene polymorphisms in patients with rheumatoid arthritis in Koreans J Korean Med Sci 2000: 15: 83-7.
34. Fu J, Ikegami H, Kawaguchi Y et al. Association of distal chromosome 2q with IDDM in Japanese subjects. Diabetologia 1998: 41: 228-32.